Pancreatic endocrine tumors (neuroendocrine tumors, NETs) are rare tumors that develop in the hormone-producing cells of the pancreas. They may be functional (producing hormones like insulin or gastrin) or non-functional (not producing hormones). Surgical resection is the primary treatment when the tumor is localized and removable, offering the best chance for long-term cure or control.
It is a growth that arises from the hormone-producing cells of the pancreas. Some produce hormones (causing symptoms like low blood sugar, stomach ulcers, or diarrhea), while others may not produce symptoms until they grow larger.
Surgery is recommended if:
Yes. In specialized centers, outcomes are excellent. Risks may include bleeding, infection, leakage from the pancreas, or delayed gastric emptying, but these are carefully managed by experienced surgical teams.
Prognosis depends on tumor type, size, and spread. For localized pancreatic NETs, surgical resection offers 5-year survival rates of 60–90%, much better than pancreatic adenocarcinoma.
Recurrence is possible, especially in aggressive tumors. Lifelong monitoring with blood tests, imaging, and check-ups is essential for early detection and management.
If you or a loved one has been diagnosed with a pancreatic endocrine tumor, the Surgical Oncology & Gastrointestinal Surgery Team at Baby Memorial Hospital (BMH) provides expert evaluation and advanced tumor resection procedures with excellent outcomes and comprehensive post-surgical care.
👉 Book an Appointment Online or visit BMH to consult our surgical oncology specialists.